Objective: The purpose of this study is to look at the burgeoning topic of neuronutrition within nutritional neuroscience, specifically how dietary factors affect brain health, cognitive adaptation, and susceptibility to neurological illnesses across the lifetime. Review framework: This narrative review brings together current information from nutritional neuroscience, clinical trials, and epidemiological investigations to investigate the link between macronutrients, neurobiological mechanisms, and cognitive outcomes. The framework brings together molecular, physiological, and behavioural aspects to provide a thorough knowledge of diet-brain interactions. Principle Theme: The review emphasises the importance of key nutrients such as proteins, carbs, fats (especially omega-3 fatty acids), vitamins, minerals, and phytonutrients in regulating brain chemistry, neurotransmitter production, neuroplasticity, and cognitive function. Core molecular pathways such as neuroinflammation, oxidative stress, and mitochondrial dysfunction are investigated in relation to neurological illnesses like Alzheimer's disease, depression, and others. The gut-brain axis is described as a bidirectional communication system that influences mood and cognition via microbial metabolites, immunological signalling, and neurotransmitter synthesis. Hormonal imbalances and gene-environment interactions are also being investigated as modulators of neurogenesis and disease vulnerability, with potential ties to metabolic illnesses such as type 2 diabetes. Nutrient deficiencies, including protein, essential fatty acids, iron, zinc, iodine, and vitamin B12, have been linked to brain growth and cognitive decline. Conclusion: Neuronutrition offers a multidisciplinary approach for examining how dietary habits influence neuronal integrity and cognitive resilience. The evidence supports the creation of specific dietary therapies aiming at improving brain health, reducing neuroinflammation, and lowering the global prevalence of neurological and metabolic illnesses. Future research should focus on mechanistic clarity and translational techniques to improve cognitive health in varied populations.
| Published in | Journal of Food and Nutrition Sciences (Volume 14, Issue 2) |
| DOI | 10.11648/j.jfns.20261402.18 |
| Page(s) | 170-179 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2026. Published by Science Publishing Group |
Neuronutrition, Nutritional Neuroscience, Brain Health, Cognitive Function, Neuroinflammation
Nutrient | Major Sources | Recommended Intake | Key Brain Functions | Evidence Type | Key Findings / Effect Pattern | Clinical Relevance | References |
|---|---|---|---|---|---|---|---|
Protein | Pulses, cereals, dairy, meat, nuts | 46–54 g | Neurotransmitter synthesis, nerve signaling | Observational, clinical nutrition studies | Adequate protein intake associated with better cognitive performance and reduced risk of mild cognitive impairment | Important for maintaining neurotransmitter balance and cognitive function during aging | [ 62] |
Carbohydrates | Whole grains, fruits, vegetables | ~120 g | Primary energy source for brain | Observational studies | Low carbohydrate intake linked with reduced psychomotor speed and memory performance | Balanced carbohydrate intake supports sustained cognitive energy metabolism | [ 45] |
DHA & EPA (Omega-3) | Fatty fish, flaxseed, walnuts | ~500 mg | Synaptic plasticity, neuronal membrane integrity | RCTs, observational studies | Consistent evidence of improved memory and learning; dosage variability across trials | Potential preventive role in cognitive decline and neurodegenerative disorders | [ 25] |
Vitamin B12 | Dairy, fermented foods, sprouts | 2.2 µg | Myelin formation, nerve impulse transmission | Observational and clinical studies | Deficiency strongly associated with cognitive decline and depressive symptoms | Screening important in elderly populations | [ 43] |
Vitamin D | Mushrooms, seafood, dairy | 400–800 IU | Regulation of neurotrophic factors | Observational studies, emerging trials | Low levels associated with increased risk of dementia and neuropsychiatric disorders | Possible role in neuroprotection but causal evidence still evolving | [4] |
Vitamin E | Nuts, seeds, vegetable oils | 15 mg | Antioxidant protection of neurons | Observational and intervention studies | Antioxidant effects may slow progression of neurodegenerative diseases | Potential supportive therapy in neurodegenerative conditions | [ 44] |
Magnesium | Nuts, leafy greens, cocoa | 370–440 mg | Synaptic transmission, neuroprotection | Mechanistic and observational studies | Deficiency linked with neuroinflammation and impaired synaptic plasticity | May support cognitive resilience and neuronal signaling | [5] |
Zinc | Meat, beans, lentils | 13–17 mg | Synaptic plasticity and neuronal signaling | Mechanistic and epidemiological studies | Dysregulated zinc homeostasis observed in neurodegenerative disorders | Important for maintaining neuronal signaling pathways | [ 36] |
Polyphenols | Berries, cocoa, tea | 200–500 mg | Antioxidant and anti-inflammatory activity | Experimental and human trials | Evidence suggests improved memory and cerebral blood flow | Potential dietary strategy for cognitive aging prevention | [ 59] |
Psychobiotics | Yogurt, kefir, fermented foods | — | Gut–brain axis modulation | Emerging human trials | May improve mood, stress response, and cognition through microbiota modulation | Promising but still developing area of neuronutrition research | [ 49] |
Intervention Nutrient | Duration & Dose | Disease/Condition | Evidence Type | Key Findings / Effect Pattern | Clinical Relevance | References |
|---|---|---|---|---|---|---|
DHA, EPA | 500–600 mg/day (3 weeks–12 months) | Depression, Anxiety | Clinical trials | Significant reduction in depression and anxiety symptoms | Supports use in mood disorder management | [50] |
Omega-3 PUFA | 840 mg EPA + 560 mg DHA/day (12 months) | Psychotic disorders | Clinical trials | Improvement in psychotic symptoms | May aid as adjunct therapy in psychiatric disorders | [1] |
Magnesium, Folic Acid | 310 mg Mg + 400 µg folic acid/day (8 weeks) | Stress management | Clinical studies | Positive effect on stress reduction | Useful in stress and mental well-being | [ 44] |
Zinc | 50 mg/day (12 weeks) | Depression with multiple sclerosis | Clinical trials | Reduction in depressive symptoms | May support mental health in chronic disease | [ 52] |
Vitamin B (B2, B6, B12) | B2: 400 mg/day (3 months); B12: 3 mg + B6: 1 mg/day (12 weeks) | Migraine; Cognitive decline with age | Clinical trials | Reduced migraine frequency; improved cognitive outcomes | Supports neurological function and aging brain health | [1 1, 53] |
Vitamin A | 30 mg/day (28 days); 25,000 IU/day (6 months) | Alzheimer’s disease; Multiple sclerosis | Clinical studies | Reduction in symptoms and disease progression | Potential neuroprotective role | [ 46, 20] |
Vitamin E | 400 IU/day (3 months) | Parkinson’s disease | Clinical trials | No significant improvement observed | Limited efficacy in this condition | [3 3] |
Vitamin C | 2 g/day (6 months); 500 mg/day (3 months) | Hyperoxia; Trauma recovery | Clinical studies | Reduction in oxidative stress and improved recovery | Supports antioxidant defense and healing | [39 , 30] |
Coenzyme Q10 | 300 mg/day (90 weeks) | Parkinson’s disease | Clinical trials | Significant improvement in disease progression | Potential therapeutic role in neurodegeneration | [ 64] |
Polyphenols | Cocoa: 250 mg/day (4 weeks); Flavonoids: 17–36 mg/day (3 years) | Mental fatigue; Cognitive function | Human trials | Improved cognition and reduced mental fatigue | Supports cognitive performance and aging | [ 38, 35] |
Prebiotics (FOS) | 5 g/day (3 weeks) | Cognitive function, stress | Clinical studies | Improved cognition and reduced stress response | Supports gut–brain axis modulation | [ 54] |
Probiotics (Lactobacillus, Bifidobacterium) | 3 weeks (animal); 30 days (human) | Mood, cognition, brain function | Animal and human studies | Improved mood, stress response, and neurotransmitter activity | Promising role in mental health via gut–brain axis | [ 32, 51] |
Neurotransmitter | Key Actions in Brain | Dietary Sources | Evidence Type | Key Findings / Effect Pattern | Clinical Relevance | References |
|---|---|---|---|---|---|---|
Acetylcholine | Modulates neuronal excitability, synaptic transmission, and synaptic plasticity | Citrus fruits, beans, peas, spinach, pumpkin | Mechanistic and nutritional studies | Choline-rich diets support acetylcholine synthesis and may enhance memory and learning processes | Important for cognitive function and may influence risk of neurodegenerative disorders such as Alzheimer’s disease | [2 6] |
Glutamate | Primary excitatory neurotransmitter; mediates synaptic plasticity and neuronal signaling | Tomato, spinach, paneer, mushrooms, fermented soy products, seafood | Mechanistic and experimental studies | Essential for learning and memory through synaptic plasticity, but excessive activity may contribute to excitotoxicity | Balanced glutamate signaling is critical for normal cognition and prevention of neuronal damage | [ 48] |
GABA | Major inhibitory neurotransmitter regulating synaptic activity and circadian rhythm | Barley, broccoli, buckwheat, oats, soybean, spinach, tea | Experimental and emerging clinical studies | GABA-modulating foods may promote relaxation and stress regulation | Potential role in managing anxiety, sleep disorders, and stress-related cognitive impairment | [3 1] |
Dopamine | Regulates motor control, motivation, cognition, and reward pathways | Banana, avocado, tomato, spinach, legumes | Mechanistic and observational studies | Dopamine precursor nutrients (e.g., tyrosine) influence motivation and cognitive performance | Dysregulation linked with Parkinson’s disease and mood disorders | [ 58] |
Serotonin | Regulates mood, sleep, anxiety, and metabolic processes | Kiwi, banana, pineapple, tomato, nuts | Observational and mechanistic studies | Tryptophan-rich foods influence serotonin synthesis and emotional regulation | Important in depression, sleep disorders, and gut–brain axis regulation | [ 19] |
Histamine | Regulates sleep–wake cycle, learning, memory, appetite, and neuroendocrine functions | Fermented foods, aged cheese, yogurt, fish products | Mechanistic and clinical studies | Histamine signaling influences alertness and cognitive arousal | Altered histamine signaling may contribute to sleep disorders and cognitive dysfunction | [ 47] |
DHA | Docosahexanoic Acid |
EPA | Eicosapentanoic Acid |
GABA | Gamma Amino Butyric Acid |
CNS | Central Nervous System |
ROS | Reactive Oxygen Species |
RNS | Reactive Nitrogen Species |
| [1] | Amminger, G. P., Nelson, B., Markulev, C., Yuen, H. P., Schäfer, M. R., Berger, M., and McGorry, P. D. (2020). The NEURAPRO biomarker analysis: Long-chain omega-3 fatty acids improve 6-month and 12-month outcomes in youths at ultra-high risk for psychosis. Biological Psychiatry, 87(3), 243-252. |
| [2] | Amor, S., Peferoen, L. A., Vogel, D. Y., Breur, M., van der Valk, P., Baker, D., and van Noort, J. M. (2014). Inflammation in neurodegenerative diseases—An update. Immunology, 142(2), 151–166. |
| [3] | Amor, S., Puentes, F., Baker, D., and van der Valk, P. (2010). Inflammation in neurodegenerative diseases. Immunology, 129(2), 154-169. |
| [4] | Annweiler, C., Schott, A. M., Rolland, Y., Blain, H., Herrmann, F. R., and Beauchet, O. (2014). Dietary intake of vitamin D and cognition in older women: A large population-based study. Neurology, 83(5), 434-440. |
| [5] | Barbagallo, M., and Dominguez, L. J. (2010). Magnesium and neurological diseases: A review of the evidence. Neurobiology of Aging, 31(8), 1205-1218. |
| [6] | Bauer, M., Silverman, D. H., Schluter, L., Kumar, A., Huda, A., and Fernandez-Miranda, J. C. (2021). Thyroid hormone replacement therapy and cognition: A randomized controlled trial. Journal of Clinical Endocrinology and Metabolism, 106(1), e281-e292. |
| [7] | Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S., and Kalayci, O. (2016). Oxidative stress and antioxidant defense. World Allergy Organization Journal, 9(1), 1–10. |
| [8] | Black, M. M., Quigg, A. M., Hurley, K. M., Pepper, M. R., Irons, S., and Reifsnider, E. (2020). Violence, food insecurity, and nutrient deficiencies interact to negatively impact children’s cognitive function. Nutrition Reviews, 78(2), 105-109. |
| [9] | Boakye, D., et al. (2020). Food-Derived Enzymes and Their Use in Functional Foods. In Reference Module in Food Science. Elsevier. |
| [10] | Bonfili, L., Cecarini, V., Berardi, S., Scarpona, S., Suchodolski, J. S., Nasuti, C., Eleuteri, A. M. (2017). Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Scientific Reports, 7, 2426. |
| [11] | Chen, Y. S., Lee, H. F., Tsai, C. H., Hsu, Y. Y., Fang, C. J., Chen, C. J., Hu, F. W. (2022). Effect of Vitamin B2 supplementation on migraine prophylaxis: A systematic review and meta-analysis. Nutritional Neuroscience, 25(9), 1801-1812. |
| [12] | Colzato, L. S., et al. (2013). Eating to stop: Tyrosine supplementation enhances inhibitory control but not response execution. Neuropsychologia, 62, 398-402. |
| [13] | Craft, S. (2021). Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and therapeutic opportunities. Trends in Endocrinology and Metabolism, 32(1), 8-19. |
| [14] | Cryan, J. F., and Dinan, T. G. (2012). Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience, 13(10), 701-712. |
| [15] | Cryan, J. F., O’Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Dinan, T. G. (2019). The microbiota–gut–brain axis. Physiological Reviews, 99(4), 1877–2013. |
| [16] | Cryan, J. F., O’Riordan, K. J., Sandhu, K., Peterson, V., and Dinan, T. G. (2020). The gut microbiome in neurological disorders. The Lancet Neurology, 19(2), 179–194. |
| [17] | Cunningham, C. (2013). Microglia and neurodegeneration: The role of systemic inflammation. Glia, 61(1), 71-90. |
| [18] | Cusick, S. E., Georgieff, M. K., Rao, R., and Makrides, M. (2021). Nutritional and toxic causes of developmental brain disorders. In R. D. Brown and M. O. Magnuson (Eds.), The Handbook of Life Course Health Development (pp. 285-300). Springer. |
| [19] | Diano, S., and Gao, X. B. (2022). Dietary sources and the role of serotonin in mood, sleep, and metabolic regulation. Nutrients, 14(11), 2298. |
| [20] | Eskelinen, M. H., Ngandu, T., Helkala, E. L., Tuomilehto, J., Nissinen, A., Soininen, H., and Kivipelto, M. (2021). Fat intake at midlife and cognitive impairment later in life: A population-based CAIDE study. International Journal of Geriatric Psychiatry, 36(2), 221-228. |
| [21] | Fernandez-Mendoza, J., Baker, J. H., and Vgontzas, A. N. (2021). Sleep and cognitive health: Socioecological perspectives. Nature Reviews Neurology, 17(2), 123-135. |
| [22] | Fotuhi, M., Mohassel, P., and Yaffe, K. (2019). Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: A complex association. Nature Clinical Practice Neurology, 5(3), 140-152. |
| [23] | Georgieff, M. K. (2017). Nutrition and the developing brain: nutrient priorities and measurement. The American Journal of Clinical Nutrition, 106(Suppl 1), 254S-260S. |
| [24] | Gómez-Pinilla, F. (2008). Brain foods: The effects of nutrients on brain function. Nature Reviews Neuroscience, 9(7), 568-578. |
| [25] | Grosso, G., Yang, J., Marventano, S., (2014). Effects of omega-3 fatty acids on cognitive performance and brain structure in older adults: A meta-analysis. Nutrition Reviews, 72(7), 447-465. |
| [26] | Gusev, E. I., and Kumar, R. (2015). The role of acetylcholine in neurocognitive function and synaptic plasticity. Frontiers in Neuroscience, 9, Article 220. |
| [27] | Halliwell, B. (2012). Free radicals and antioxidants: updating a personal view. Nutrition Reviews, 70(5), 257-265. |
| [28] | Halliwell, B., and Gutteridge, J. M. C. (2015). Free radicals in biology and medicine (5th ed.). Oxford University Press. |
| [29] | Heneka, M. T., Kummer, M. P., and Latz, E. (2014). Innate immune activation in neurodegenerative disease. Nature Reviews Immunology, 14(7), 463-477. |
| [30] | Jain, S. K., Dar, M. Y., Kumar, S., Yadav, A., and Kearns, S. R. (2019). Role of antioxidant (Vitamin-C) in post-operative pain relief in foot and ankle trauma surgery: A prospective randomized trial. Foot and Ankle Surgery, 25(6), 542-545. |
| [31] | Jang, S. Y., and Kim, M. S. (2020). The role of gamma-aminobutyric acid (GABA) in brain function and its dietary sources. Nutrients, 12(9), 2617. |
| [32] | Kelly, J. R., et al. (2016). Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. Journal of Psychiatric Research, 82, 109-118. |
| [33] | Kim, Y., and Lee, J. H. (2015). The role of vitamin C in neurocognitive function: A review of the evidence. Frontiers in Aging Neuroscience, 7, Article 129. |
| [34] | Leng, F., and Edison, P. (2021). Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here? Nature Reviews Neurology, 17(3), 157–172. |
| [35] | Letenneur, L., Proust-Lima, C., Le Gouge, A., Dartigues, J. F., and Barberger-Gateau, P. (2007). Flavonoid intake and cognitive decline over a 10-year period. American Journal of Epidemiology, 165(12), 1364-1371. |
| [36] | Li, Y., Zhang, X., and Lu, Y. (2014). Zinc and neurodegenerative diseases: A review of the evidence. Frontiers in Aging Neuroscience, 6, Article 250. |
| [37] | Mahoney, C. R., et al. (2007). Tyrosine supplementation mitigates working memory decrements during cold exposure. Physiology and Behavior, 92(4), 575-582. |
| [38] | Massee, L. A., Ried, K., Pase, M., Travica, N., Yoganathan, J., Scholey, A., and Pipingas, A. (2015). The acute and sub-chronic effects of cocoa flavanols on mood, cognitive and cardiovascular health in young healthy adults: A randomized, controlled trial. Frontiers in Pharmacology, 6, Article 93. |
| [39] | McCann, J. C., and Ames, B. N. (2008). Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? The FASEB Journal, 22(4), 982-1001. |
| [40] | McGowan, P. O., Sasaki, A., D’Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., and Meaney, M. J. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nature Neuroscience, 12(3), 342-348. |
| [41] | Messaoudi, M., et al. (2011). Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition, 105(5), 755-764. |
| [42] | Norden, D. M., and Godbout, J. P. (2013). Review: Microglia of the aged brain: Primed to be activated and resistant to regulation. Neuropathology and Applied Neurobiology, 39(1), 19–34. |
| [43] | O'Leary, F., and Samman, S. (2010). Vitamin B12 deficiency and cognitive impairment: A review of the evidence. Nutrition Reviews, 68(12), 725-740. |
| [44] | Oliver-Baxter, J. M., Whitford, H. S., Turnbull, D. A., and Bond, M. J. (2018). Effects of vitamin supplementation on inflammatory markers and psychological wellbeing among distressed women: A randomized controlled trial. Journal of Integrative Medicine, 16(5), 322-328. |
| [45] | O'Neil, C. E., Fulgoni, V. L., and Nicklas, T. A. (2014). Carbohydrates, brain function, and cognitive health: A review of the evidence. Nutrition Reviews, 72(8), 527-537. |
| [46] | Prema, A., Janakiraman, U., Manivasagam, T., and Thenmozhi, A. J. (2015). Neuroprotective effect of lycopene against MPTP induced experimental Parkinson’s disease in mice. Neuroscience Letters, 599, 12-19. |
| [47] | Rausch, W. D., and Schneider, G. (2021). The role of L-histidine in neurological function and its dietary sources. Frontiers in Nutrition, 8, Article 687579. |
| [48] | Reiner, A., and Voigt, T. (2018). The role of glutamate in brain function and neurological disorders: A review. Frontiers in Molecular Neuroscience, 11, Article 273. |
| [49] | Rizzetto, L., and Reddy, V. S. (2018). The role of psychobiotics in cognitive health: A review of recent evidence. Nutrients, 10(12), 2002. |
| [50] | Robinson, D. G., Gallego, J. A., John, M., Hanna, L. A., Zhang, J. P., Birnbaum, M. L., and Szeszko, P. R. (2019). A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16-week randomized placebo-controlled trial for participants concurrently treated with risperidone. Schizophrenia Research, 204, 295-303. |
| [51] | Rosenbaum, D. L., and White, K. S. (2019). The role of hormonal factors in managing depression in women. Journal of Nurse Practitioners, 15(2), 141-145. |
| [52] | Salari, S., Khomand, P., Arasteh, M., Yousefzamani, B., and Hassanzadeh, K. (2015). Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial. Pharmacological Reports, 67, 606-609. |
| [53] | Scheltens, P., Kamphuis, P. J., Verhey, F. R., Rikkert, M. G. O., Wurtman, R. J., Wilkinson, D., and Kurz, A. (2010). Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial. Alzheimer's and Dementia, 6(1), 1-10. |
| [54] | Schmidt, K., et al. (2015). Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology, 232(10), 1793-1801. |
| [55] | Sharon, G., Sampson, T. R., Geschwind, D. H., and Mazmanian, S. K. (2016). The central nervous system and the gut microbiome. Cell, 167(4), 915-932. |
| [56] | Sies, H. (2015). Oxidative stress: a concept in redox biology and medicine. Redox Biology, 4, 180-183. |
| [57] | Sies, H., and Jones, D. P. (2020). Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nature Reviews Molecular Cell Biology, 21(7), 363-383. |
| [58] | Smith, D. L., and Jones, K. A. (2021). Dietary influences on dopamine function: A review of recent research. Journal of Nutritional Biochemistry, 89, 108580. |
| [59] | Spencer, J. P. E., Vafeiadou, K., and Williams, R. J. (2012). Polyphenols and cognitive function: A review of recent evidence. Neurobiology of Aging, 33(4), 662-674. |
| [60] | Tönnies, E., and Trushina, E. (2017). Oxidative stress, synaptic dysfunction, and Alzheimer’s disease. Journal of Alzheimer’s Disease, 57(4), 1105–1121. |
| [61] | Victora, C. G., Bahl, R., Barros, A. J. D., França, G. V. A., Horton, S., Krasevec, J., Murch, S., Sankar, M. J., Walker, N., and Rollins, N. C. (2016). Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong effect. The Lancet, 387(10017), 475-490. |
| [62] | Wang, W., Zhao, F., Ma, X., Perry, G., and Zhu, X. (2020). Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease. Neurochemistry International, 134, 104632. |
| [63] | Weikert, C., Boeing, H., Schink, M., and et al. (2004). Dietary protein intake and cognitive function in older adults: Results from the Three-City Study. American Journal of Clinical Nutrition, 80(6), 1416-1422. |
| [64] | Yoritaka, A., Kawajiri, S., Yamamoto, Y., Nakahara, T., Ando, M., Hashimoto, K., and Hattori, N. (2015). Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease. Parkinsonism and Related Disorders, 21(8), 911-916. |
| [65] | Yurko-Mauro, K., Alexander, D. D., and Van Elswyk, M. E. (2015). Docosahexaenoic acid and adult memory: A systematic review and meta-analysis. PLOS ONE, 10(3), e0120391. |
APA Style
Jangra, S., Choudhary, M., Saikia, N., Kaur, P., Singh, S. (2026). Neuronutrition-the Link Between Diet and Cognitive Adaptability. Journal of Food and Nutrition Sciences, 14(2), 170-179. https://doi.org/10.11648/j.jfns.20261402.18
ACS Style
Jangra, S.; Choudhary, M.; Saikia, N.; Kaur, P.; Singh, S. Neuronutrition-the Link Between Diet and Cognitive Adaptability. J. Food Nutr. Sci. 2026, 14(2), 170-179. doi: 10.11648/j.jfns.20261402.18
@article{10.11648/j.jfns.20261402.18,
author = {Shalini Jangra and Monika Choudhary and Nirja Saikia and Prabhdeep Kaur and Shristi Singh},
title = {Neuronutrition-the Link Between Diet and Cognitive Adaptability},
journal = {Journal of Food and Nutrition Sciences},
volume = {14},
number = {2},
pages = {170-179},
doi = {10.11648/j.jfns.20261402.18},
url = {https://doi.org/10.11648/j.jfns.20261402.18},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jfns.20261402.18},
abstract = {Objective: The purpose of this study is to look at the burgeoning topic of neuronutrition within nutritional neuroscience, specifically how dietary factors affect brain health, cognitive adaptation, and susceptibility to neurological illnesses across the lifetime. Review framework: This narrative review brings together current information from nutritional neuroscience, clinical trials, and epidemiological investigations to investigate the link between macronutrients, neurobiological mechanisms, and cognitive outcomes. The framework brings together molecular, physiological, and behavioural aspects to provide a thorough knowledge of diet-brain interactions. Principle Theme: The review emphasises the importance of key nutrients such as proteins, carbs, fats (especially omega-3 fatty acids), vitamins, minerals, and phytonutrients in regulating brain chemistry, neurotransmitter production, neuroplasticity, and cognitive function. Core molecular pathways such as neuroinflammation, oxidative stress, and mitochondrial dysfunction are investigated in relation to neurological illnesses like Alzheimer's disease, depression, and others. The gut-brain axis is described as a bidirectional communication system that influences mood and cognition via microbial metabolites, immunological signalling, and neurotransmitter synthesis. Hormonal imbalances and gene-environment interactions are also being investigated as modulators of neurogenesis and disease vulnerability, with potential ties to metabolic illnesses such as type 2 diabetes. Nutrient deficiencies, including protein, essential fatty acids, iron, zinc, iodine, and vitamin B12, have been linked to brain growth and cognitive decline. Conclusion: Neuronutrition offers a multidisciplinary approach for examining how dietary habits influence neuronal integrity and cognitive resilience. The evidence supports the creation of specific dietary therapies aiming at improving brain health, reducing neuroinflammation, and lowering the global prevalence of neurological and metabolic illnesses. Future research should focus on mechanistic clarity and translational techniques to improve cognitive health in varied populations.},
year = {2026}
}
TY - JOUR T1 - Neuronutrition-the Link Between Diet and Cognitive Adaptability AU - Shalini Jangra AU - Monika Choudhary AU - Nirja Saikia AU - Prabhdeep Kaur AU - Shristi Singh Y1 - 2026/04/20 PY - 2026 N1 - https://doi.org/10.11648/j.jfns.20261402.18 DO - 10.11648/j.jfns.20261402.18 T2 - Journal of Food and Nutrition Sciences JF - Journal of Food and Nutrition Sciences JO - Journal of Food and Nutrition Sciences SP - 170 EP - 179 PB - Science Publishing Group SN - 2330-7293 UR - https://doi.org/10.11648/j.jfns.20261402.18 AB - Objective: The purpose of this study is to look at the burgeoning topic of neuronutrition within nutritional neuroscience, specifically how dietary factors affect brain health, cognitive adaptation, and susceptibility to neurological illnesses across the lifetime. Review framework: This narrative review brings together current information from nutritional neuroscience, clinical trials, and epidemiological investigations to investigate the link between macronutrients, neurobiological mechanisms, and cognitive outcomes. The framework brings together molecular, physiological, and behavioural aspects to provide a thorough knowledge of diet-brain interactions. Principle Theme: The review emphasises the importance of key nutrients such as proteins, carbs, fats (especially omega-3 fatty acids), vitamins, minerals, and phytonutrients in regulating brain chemistry, neurotransmitter production, neuroplasticity, and cognitive function. Core molecular pathways such as neuroinflammation, oxidative stress, and mitochondrial dysfunction are investigated in relation to neurological illnesses like Alzheimer's disease, depression, and others. The gut-brain axis is described as a bidirectional communication system that influences mood and cognition via microbial metabolites, immunological signalling, and neurotransmitter synthesis. Hormonal imbalances and gene-environment interactions are also being investigated as modulators of neurogenesis and disease vulnerability, with potential ties to metabolic illnesses such as type 2 diabetes. Nutrient deficiencies, including protein, essential fatty acids, iron, zinc, iodine, and vitamin B12, have been linked to brain growth and cognitive decline. Conclusion: Neuronutrition offers a multidisciplinary approach for examining how dietary habits influence neuronal integrity and cognitive resilience. The evidence supports the creation of specific dietary therapies aiming at improving brain health, reducing neuroinflammation, and lowering the global prevalence of neurological and metabolic illnesses. Future research should focus on mechanistic clarity and translational techniques to improve cognitive health in varied populations. VL - 14 IS - 2 ER -